Prevalent cases for digestive congenital anomalies among aged 0–14 years in 2021, the percentage change in ASRs per 100 000 and EAPC by GBD region, from 1990 to 2021 (generated from the data available at https://vizhub.healthdata.org/gbd-results/)
| Prevalence (95% UI) | ||||
| No, in thousands (95% UI) | ASRs per 100 000 (95% UI) | Percentage change in ASRs from 1990 to 2021 | EAPC (1990–2021) (95% UI) | |
| Global | 2206.79 (1734.74 to 2735.1) | 45.09 (36.64 to 54.19) | −8.15 (−14.04 to −1.8) | −0.27 (−0.32 to −0.23) |
| High-income Asia Pacific | 24.06 (19.02 to 29.12) | 48.56 (39.22 to 57.38) | −3.48 (−8.82 to 2.6) | −0.06 (−0.21 to 0.09) |
| High-income North America | 68.6 (55.33 to 83.42) | 47.04 (39.49 to 54.44) | −6.4 (−13.89 to 1.88) | −0.07 (−0.15 to 0.01) |
| Western Europe | 78.19 (63.87 to 94.89) | 51.54 (42.75 to 61.21) | −8.17 (−13.16 to −3.71) | −0.32 (−0.34 to −0.3) |
| Australasia | 3.98 (3.11 to 4.89) | 28.28 (22.96 to 33.56) | −5.94 (−15.04 to 3.87) | −0.53 (−0.63 to −0.43) |
| Andean Latin America | 29.54 (23.13 to 37.63) | 68.49 (54.93 to 83.79) | 10.19 (−0.71 to 23.29) | 0.27 (0.18 to 0.36) |
| Tropical Latin America | 107.38 (86.11 to 132.64) | 86.52 (70.56 to 103.38) | −7.68 (−16.5 to 2.16) | −0.25 (−0.28 to −0.21) |
| Central Latin America | 81.46 (65.23 to 98.93) | 54.26 (44.66 to 64.09) | 11.16 (3.07 to 20.64) | 0.32 (0.22 to 0.43) |
| Southern Latin America | 18.27 (14.28 to 22.31) | 52.54 (42.72 to 62.11) | 38.05 (22.34 to 56.25) | 0.92 (0.76 to 1.08) |
| Caribbean | 19.3 (15.23 to 24.06) | 67.86 (55.53 to 81.41) | −11.15 (−18.02 to −4.66) | −0.41 (−0.48 to −0.33) |
| Central Europe | 15.63 (12.26 to 19.01) | 36.23 (29.74 to 42.78) | −16.3 (−21.91 to −9.85) | −0.56 (−0.6 to −0.53) |
| Eastern Europe | 37.63 (29.96 to 46.25) | 47.5 (38.41 to 56.18) | −7.63 (−12.38 to −2.63) | −0.29 (−0.38 to −0.21) |
| Central Asia | 39.57 (31.18 to 49.68) | 58.77 (47.54 to 70.44) | 9.98 (1.59 to 18.99) | 0.39 (0.34 to 0.44) |
| North Africa and Middle East | 212.13 (167.12 to 262.39) | 50.57 (40.88 to 59.51) | −10.55 (−18.88 to −2.04) | −0.41 (−0.46 to −0.37) |
| South Asia | 470.43 (364.27 to 595.31) | 39.49 (31.32 to 48.78) | −11.43 (−20.06 to −1.83) | −0.32 (−0.4 to −0.25) |
| Southeast Asia | 169.27 (133.05 to 209.26) | 40.47 (32.89 to 48.29) | −2.48 (−11.28 to 7.3) | −0.14 (−0.18 to −0.09) |
| East Asia | 277.1 (209.16 to 345.5) | 40.06 (31.76 to 48.82) | −10.47 (−20.82 to 3.17) | −0.2 (−0.29 to −0.12) |
| Oceania | 5.3 (4.08 to 6.75) | 41.59 (33.21 to 51.15) | 7.53 (−1.71 to 19.49) | 0.18 (0.08 to 0.27) |
| Western sub-Saharan Africa | 269.66 (207.96 to 334.32) | 48.18 (38.88 to 57.8) | −4.58 (−11.78 to 3.72) | −0.26 (−0.35 to −0.17) |
| Eastern sub-Saharan Africa | 194.24 (152.15 to 242.44) | 43.2 (35.14 to 52.54) | −17.39 (−24.99 to −8.04) | −0.6 (−0.66 to −0.53) |
| Central sub-Saharan Africa | 61.89 (48.28 to 78.81) | 42.45 (34.53 to 51.86) | −18.82 (−29.16 to −6.85) | −0.76 (−0.85 to −0.67) |
| Southern sub-Saharan Africa | 23.17 (18.29 to 28.69) | 41.74 (33.86 to 49.87) | 2.48 (−4.34 to 11.58) | 0.14 (0 to 0.27) |
ASRs, age-standardised rates; EAPC, estimated annual percentage change; GBD, Global Burden of Disease; 95% UI, 95% uncertainty interval.